Augmented increase in tight junction permeability by luminal stimuli in the non-inflamed ileum of Crohn's disease.
BACKGROUND
Crohn's disease is associated with deranged intestinal permeability in vivo, suggesting dysfunction of tight junctions. The luminal contents are important for development of neoinflammation following resection. Regulation of tight junctions by luminal factors has not previously been studied in Crohn's disease.


OBJECTIVE
The aim of the study was to investigate the effects of a luminal stimulus, known to affect tight junctions, on the distal ileum in patients with Crohn's disease.


METHODS
Surgical specimens from the distal ileum of patients with Crohn's disease (n=12) were studied, and ileal specimens from colon cancer patients (n=13) served as controls.


METHODS
Mucosal permeability to 51Cr-EDTA and electrical resistance were studied in Ussing chambers during luminal exposure to sodium caprate (a constituent of milk fat, affecting tight junctions) or to buffer only. The mechanisms involved were studied by mucosal ATP levels, and by electron and confocal microscopy.


RESULTS
Baseline permeability was the same in non-inflamed ileum of Crohn's disease and controls. Sodium caprate induced a rapid increase in paracellular permeability--that is, increased permeation of 51Cr-EDTA and decreased electrical resistance--which was more pronounced in non-inflamed ileum of Crohn's disease, and electron microscopy showed dilatations within the tight junctions. Moreover, sodium caprate induced disassembly of perijunctional filamentous actin was more pronounced in Crohn's disease mucosa. Mucosal permeability changes were accompanied by mitochondrial swelling and a fall in epithelial ATP content, suggesting uncoupling of oxidative phosphorylation.


CONCLUSIONS
The tight junctions in the non-inflamed distal ileum of Crohn's disease were more reactive to luminal stimuli, possibly mediated via disturbed cytoskeletal contractility. This could contribute to the development of mucosal neoinflammation in Crohn's disease.
Söderholm
J D
JD
Department of Surgery and Clinical Research Centre, University Hospital, Linköping, Sweden. johda@ibk.liu.se
Olaison
G
G
Peterson
K H
KH
Franzén
L E
LE
Lindmark
T
T
Wirén
M
M
Tagesson
C
C
Sjödahl
R
R
D000199:Actins / Q000032:analysis; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003113:Colonoscopy; D003424:Crohn Disease / Q000473:pathology / Q000503:physiopathology*; D003652:Decanoic Acids / Q000494:pharmacology; D015194:Diffusion Chambers, Culture; D004594:Electrophysiology; D020895:Enterocytes / Q000648:ultrastructure; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007082:Ileum / Q000503:physiopathology* / Q000648:ultrastructure; D007408:Intestinal Absorption / Q000502:physiology; D007413:Intestinal Mucosa / Q000503:physiopathology / Q000648:ultrastructure; D008297:Male; D008875:Middle Aged; D008928:Mitochondria / Q000648:ultrastructure; D010539:Permeability / Q000187:drug effects; D019108:Tight Junctions / Q000502:physiology* / Q000648:ultrastructure
D000199:Actins; D003652:Decanoic Acids; C031071:decanoic acid